nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist
|
Patel, Dhiren |
|
2019 |
36 |
5 |
p. 1031-1051 |
artikel |
2 |
A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus
|
Hu, Xia |
|
2019 |
36 |
5 |
p. 1132-1142 |
artikel |
3 |
A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
|
Johansen, Pierre |
|
2019 |
36 |
5 |
p. 1190-1199 |
artikel |
4 |
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group
|
Filosto, Massimiliano |
|
2019 |
36 |
5 |
p. 1177-1189 |
artikel |
5 |
Bloating and Abdominal Distension: Clinical Approach and Management
|
Mari, Amir |
|
2019 |
36 |
5 |
p. 1075-1084 |
artikel |
6 |
Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
|
Johansen, Pierre |
|
2019 |
36 |
5 |
p. 1200 |
artikel |
7 |
Correction to: Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
|
Tanihara, Hidenobu |
|
2019 |
36 |
5 |
p. 1233-1234 |
artikel |
8 |
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China
|
Guan, Haijing |
|
2019 |
36 |
5 |
p. 1114-1125 |
artikel |
9 |
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different
|
Cheng, Alice Y. Y. |
|
2019 |
36 |
5 |
p. 1018-1030 |
artikel |
10 |
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
|
Zhou, Zhou |
|
2019 |
36 |
5 |
p. 1100-1113 |
artikel |
11 |
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
|
Zhou, Zhou |
|
|
36 |
5 |
p. 1100-1113 |
artikel |
12 |
Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials
|
Honvo, Germain |
|
2019 |
36 |
5 |
p. 1085-1099 |
artikel |
13 |
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease
|
Barczi, Eniko |
|
2019 |
36 |
5 |
p. 1221-1232 |
artikel |
14 |
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
|
Borgå, Olof |
|
2019 |
36 |
5 |
p. 1150-1163 |
artikel |
15 |
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
|
Francque, Sven |
|
2019 |
36 |
5 |
p. 1052-1074 |
artikel |
16 |
Reporting Clinical Trial Results of Phytomedicines in Acute Rhinosinusitis: Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi: 10.1007/s12325-018-0736-7
|
Bachert, Claus |
|
2019 |
36 |
5 |
p. 1011-1013 |
artikel |
17 |
Response Letter Addressing Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi:10.1007/s12325-018-0736-7
|
Gottschlich, Stefan |
|
2019 |
36 |
5 |
p. 1014-1017 |
artikel |
18 |
Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1
|
Dabbous, Omar |
|
2019 |
36 |
5 |
p. 1164-1176 |
artikel |
19 |
Switching “Real-World” Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control
|
Tentolouris, Nikolaos |
|
2019 |
36 |
5 |
p. 1201-1210 |
artikel |
20 |
Switching “Real-World” Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control
|
Tentolouris, Nikolaos |
|
|
36 |
5 |
p. 1201-1210 |
artikel |
21 |
The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview
|
Contesse, Marielle G. |
|
2019 |
36 |
5 |
p. 997-1010 |
artikel |
22 |
The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview
|
Contesse, Marielle G. |
|
|
36 |
5 |
p. 997-1010 |
artikel |
23 |
The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding
|
Koyuncu, Nazmiye |
|
2019 |
36 |
5 |
p. 1143-1149 |
artikel |
24 |
The Effectiveness, Safety, and Tolerability of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Retrospective Study
|
Hanta, Ismail |
|
2019 |
36 |
5 |
p. 1126-1131 |
artikel |
25 |
Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study
|
Yang, Qiong |
|
2019 |
36 |
5 |
p. 1211-1220 |
artikel |